212 related articles for article (PubMed ID: 17140563)
1. Cloning and expression of canine glucagon receptor and its use to evaluate glucagon receptor antagonists in vitro and in vivo.
Yang X; Yates ML; Candelore MR; Feeney W; Hora D; Kim RM; Parmee ER; Berger JP; Zhang BB; Qureshi SA
Eur J Pharmacol; 2007 Jan; 555(1):8-16. PubMed ID: 17140563
[TBL] [Abstract][Full Text] [Related]
2. Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists.
Dallas-Yang Q; Shen X; Strowski M; Brady E; Saperstein R; Gibson RE; Szalkowski D; Qureshi SA; Candelore MR; Fenyk-Melody JE; Parmee ER; Zhang BB; Jiang G
Eur J Pharmacol; 2004 Oct; 501(1-3):225-34. PubMed ID: 15464082
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of the glucagon receptor from cynomologous monkey.
McNally T; Grihalde ND; Pederson TM; Ogiela CA; Djuric SW; Collins CA; Lin CW; Reilly RM
Peptides; 2004 Jul; 25(7):1171-8. PubMed ID: 15245877
[TBL] [Abstract][Full Text] [Related]
4. Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.
Leffler A; Ahlstedt I; Engberg S; Svensson A; Billger M; Oberg L; Bjursell MK; Lindström E; von Mentzer B
Biochem Pharmacol; 2009 May; 77(9):1522-30. PubMed ID: 19426690
[TBL] [Abstract][Full Text] [Related]
5. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the chicken galanin type I receptor (GalR1) and a novel GalR1-like receptor (GalR1-L).
Ho JC; Kwok AH; Zhao D; Wang Y; Leung FC
Gen Comp Endocrinol; 2011 Jan; 170(2):391-400. PubMed ID: 20977910
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors.
Hess JF; Hey PJ; Chen TB; O'Brien J; Omalley SS; Pettibone DJ; Chang RS
Biol Chem; 2001 Jan; 382(1):123-9. PubMed ID: 11258662
[TBL] [Abstract][Full Text] [Related]
8. Molecular identification and characterization of the dog motilin receptor.
Ohshiro H; Nonaka M; Ichikawa K
Regul Pept; 2008 Feb; 146(1-3):80-7. PubMed ID: 17870192
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of chicken prostaglandin E receptor subtypes 2 and 4 (EP2 and EP4).
Kwok AH; Wang Y; Wang CY; Leung FC
Gen Comp Endocrinol; 2008 Jun; 157(2):99-106. PubMed ID: 18486942
[TBL] [Abstract][Full Text] [Related]
10. Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor.
Cohen SM; Duffy JL; Miller C; Kirk BA; Candelore MR; Ding VD; Kaczorowski G; Tota LM; Werrmann JG; Wright M; Parmee ER; Tata JR; Zhang BB
Bioorg Med Chem; 2006 Mar; 14(5):1506-17. PubMed ID: 16256355
[TBL] [Abstract][Full Text] [Related]
11. pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity.
Kohn WD; Micanovic R; Myers SL; Vick AM; Kahl SD; Zhang L; Strifler BA; Li S; Shang J; Beals JM; Mayer JP; DiMarchi RD
Peptides; 2007 Apr; 28(4):935-48. PubMed ID: 17328992
[TBL] [Abstract][Full Text] [Related]
12. Expression of glucagon receptors in tetracycline-inducible HEK293S GnT1- stable cell lines: an approach toward purification of receptor protein for structural studies.
Unson CG
Biopolymers; 2008; 90(3):287-96. PubMed ID: 18260137
[TBL] [Abstract][Full Text] [Related]
13. Characterization of glucagon-like peptide 1 receptor (GLP1R) gene in chickens: functional analysis, tissue distribution, and identification of its transcript variants.
Huang G; Li J; Fu H; Yan Z; Bu G; He X; Wang Y
Domest Anim Endocrinol; 2012 Jul; 43(1):1-15. PubMed ID: 22417644
[TBL] [Abstract][Full Text] [Related]
14. Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity.
Mapelli C; Natarajan SI; Meyer JP; Bastos MM; Bernatowicz MS; Lee VG; Pluscec J; Riexinger DJ; Sieber-McMaster ES; Constantine KL; Smith-Monroy CA; Golla R; Ma Z; Longhi DA; Shi D; Xin L; Taylor JR; Koplowitz B; Chi CL; Khanna A; Robinson GW; Seethala R; Antal-Zimanyi IA; Stoffel RH; Han S; Whaley JM; Huang CS; Krupinski J; Ewing WR
J Med Chem; 2009 Dec; 52(23):7788-99. PubMed ID: 19702274
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors.
Engberg S; Ahlstedt I; Leffler A; Lindström E; Kristensson E; Svensson A; Påhlman I; Johansson A; Drmota T; von Mentzer B
Biochem Pharmacol; 2007 Jan; 73(2):259-69. PubMed ID: 17097619
[TBL] [Abstract][Full Text] [Related]
16. New beta-alanine derivatives are orally available glucagon receptor antagonists.
Lau J; Behrens C; Sidelmann UG; Knudsen LB; Lundt B; Sams C; Ynddal L; Brand CL; Pridal L; Ling A; Kiel D; Plewe M; Shi S; Madsen P
J Med Chem; 2007 Jan; 50(1):113-28. PubMed ID: 17201415
[TBL] [Abstract][Full Text] [Related]
17. A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
Rivera N; Everett-Grueter CA; Edgerton DS; Rodewald T; Neal DW; Nishimura E; Larsen MO; Jacobsen LO; Kristensen K; Brand CL; Cherrington AD
J Pharmacol Exp Ther; 2007 May; 321(2):743-52. PubMed ID: 17308040
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
Jensen TN; Nielsen J; Frederiksen K; Ebert B
Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
[TBL] [Abstract][Full Text] [Related]
19. Localization and regulation of glucagon receptors in the chick eye and preproglucagon and glucagon receptor expression in the mouse eye.
Feldkaemper MP; Burkhardt E; Schaeffel F
Exp Eye Res; 2004 Sep; 79(3):321-9. PubMed ID: 15336494
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor.
Liang R; Abrardo L; Brady EJ; Candelore MR; Ding V; Saperstein R; Tota LM; Wright M; Mock S; Tamvakopolous C; Tong S; Zheng S; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2007 Feb; 17(3):587-92. PubMed ID: 17126016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
